20/20 GeneSystems, Weizmann's Yeda Collaborate on Lung Cancer Test | GenomeWeb

NEW YORK (GenomeWeb News) – Cancer diagnostics firm 20/20 GeneSystems and Yeda R&D, the technology transfer company of the Weizmann Institute of Science, today announced a collaboration aimed at commercializing a lung cancer test developed by researchers at Weizmann.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: genome sequencing study of Yakutian horses, tardigrade genome, and more.

A guest post at Retraction Watch discusses what funders can do to improve research reproducibility.

Researchers report in Nature this week that farming led to genomic adaptations in humans.

The FDA argues that it needs to evaluate the safety and efficacy of laboratory-developed tests, a proposal that divides Republicans.